Table 5.
Univariate analysis in the surgical subgroup.
| Surgical patients (n = 51) | Favorable outcome (n = 24) | Unfavorable outcome (n = 27) | p | |
|---|---|---|---|---|
| Age | 55 (49–63) | 54 (48.5–59.5) | 58 (51–63) | 0.241 |
| Initial GCS score | 4 (3–5) | 5 (4–7) | 3 (3–4) | <0.001 |
| NIHSS on admission | 38 (36–40) | 36 (32–38) | 40 (38–40) | <0.001 |
| Sex | 0.135 | |||
| Male | 35 (68.6%) | 14 (58.3%) | 21 (22.2%) | |
| Female | 16 (31.4%) | 10 (41.7%) | 6 (77.8%) | |
| SBP on admission | 172 (157–187) | 172.5 (161–190) | 172 (147.5–184.5) | 0.433 |
| DBP on admission | 99 (92–107) | 99 (94–106) | 96 (88–107) | 0.597 |
| Medical history | ||||
| Smoking (yes) | 31 (60.8%) | 11 (45.8%) | 20 (74.1%) | 0.039 |
| Diabetes (yes) | 7 (13.7%) | 1 (4.2%) | 6 (22.2%) | 0.061 |
| Hyperlipidemia (yes) | 9 (17.6%) | 3 (12.5%) | 6 (22.2%) | 0.363 |
| Medication before HBSH | ||||
| Anticoagulant drugs | 1 (0.2%) | 1 (4.2%) | 0 | 0.284 |
| Antiplatelet drugs | 4 (7.8%) | 0 | 4 (14.8%) | 0.051 |
| Irregular Antihypertensive Therapy(yes) | 40 (78.4%) | 20 (83.3%) | 20 (74.1%) | 0.422 |
| Hematoma volume (mL) | 7.6 (6.5–9.7) | 6.9 (6.2–7.6) | 9.6 (7.3–11.4) | 0.001 |
| Location of hemorrhage | 0.001 | |||
| Unilateral tegmental | 7 (13.7%) | 7 (29.2%) | 0 | |
| Bilateral tegmental | 9 (17.6%) | 7 (29.2%) | 2 (7.4%) | |
| Basal-tegmental | 18 (35.3%) | 7 (29.2%) | 11 (40.7%) | |
| Massive | 17 (33.3%) | 3 (12.5%) | 14 (51.9%) | |
| Complications | ||||
| Central hyperthermia | 23 (45.1%) | 8 (33.3%) | 15 (55.6%) | 0.111 |
| Stress ulcers | 22 (43.1%) | 7 (29.2%) | 15 (55.6%) | 0.058 |
| Time from event to operation(h) | 6 (3–12) | 5 (3–15) | 6 (4.5–12) | 0.489 |
GCS, Glasgow Score Scale; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin scale.